Proteogenomics analysis unveils a TFG-RET gene fusion and druggable targets in papillary thyroid carcinomas

Papillary thyroid cancer (PTC) is one of the most common type of endocrine malignancy. Here, the authors use proteogenomic approaches to analyse the primary tumour and lymph node metastases from a PTC patient and report an oncogenic RET fusion, and potential druggable targets from the ubiquitin sign...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Aswini Krishnan, Jean Berthelet, Emilie Renaud, Sebastian Rosigkeit, Ute Distler, Eric Stawiski, Jing Wang, Zora Modrusan, Marc Fiedler, Mariann Bienz, Stefan Tenzer, Arno Schad, Wilfried Roth, Bernd Thiede, Somasekar Seshagiri, Thomas J. Musholt, Krishnaraj Rajalingam
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Q
Acceso en línea:https://doaj.org/article/d0a0473fc75243f2b229229426d6900d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d0a0473fc75243f2b229229426d6900d
record_format dspace
spelling oai:doaj.org-article:d0a0473fc75243f2b229229426d6900d2021-12-02T15:37:20ZProteogenomics analysis unveils a TFG-RET gene fusion and druggable targets in papillary thyroid carcinomas10.1038/s41467-020-15955-w2041-1723https://doaj.org/article/d0a0473fc75243f2b229229426d6900d2020-04-01T00:00:00Zhttps://doi.org/10.1038/s41467-020-15955-whttps://doaj.org/toc/2041-1723Papillary thyroid cancer (PTC) is one of the most common type of endocrine malignancy. Here, the authors use proteogenomic approaches to analyse the primary tumour and lymph node metastases from a PTC patient and report an oncogenic RET fusion, and potential druggable targets from the ubiquitin signaling machinery for treating human PTCs.Aswini KrishnanJean BertheletEmilie RenaudSebastian RosigkeitUte DistlerEric StawiskiJing WangZora ModrusanMarc FiedlerMariann BienzStefan TenzerArno SchadWilfried RothBernd ThiedeSomasekar SeshagiriThomas J. MusholtKrishnaraj RajalingamNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-16 (2020)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Aswini Krishnan
Jean Berthelet
Emilie Renaud
Sebastian Rosigkeit
Ute Distler
Eric Stawiski
Jing Wang
Zora Modrusan
Marc Fiedler
Mariann Bienz
Stefan Tenzer
Arno Schad
Wilfried Roth
Bernd Thiede
Somasekar Seshagiri
Thomas J. Musholt
Krishnaraj Rajalingam
Proteogenomics analysis unveils a TFG-RET gene fusion and druggable targets in papillary thyroid carcinomas
description Papillary thyroid cancer (PTC) is one of the most common type of endocrine malignancy. Here, the authors use proteogenomic approaches to analyse the primary tumour and lymph node metastases from a PTC patient and report an oncogenic RET fusion, and potential druggable targets from the ubiquitin signaling machinery for treating human PTCs.
format article
author Aswini Krishnan
Jean Berthelet
Emilie Renaud
Sebastian Rosigkeit
Ute Distler
Eric Stawiski
Jing Wang
Zora Modrusan
Marc Fiedler
Mariann Bienz
Stefan Tenzer
Arno Schad
Wilfried Roth
Bernd Thiede
Somasekar Seshagiri
Thomas J. Musholt
Krishnaraj Rajalingam
author_facet Aswini Krishnan
Jean Berthelet
Emilie Renaud
Sebastian Rosigkeit
Ute Distler
Eric Stawiski
Jing Wang
Zora Modrusan
Marc Fiedler
Mariann Bienz
Stefan Tenzer
Arno Schad
Wilfried Roth
Bernd Thiede
Somasekar Seshagiri
Thomas J. Musholt
Krishnaraj Rajalingam
author_sort Aswini Krishnan
title Proteogenomics analysis unveils a TFG-RET gene fusion and druggable targets in papillary thyroid carcinomas
title_short Proteogenomics analysis unveils a TFG-RET gene fusion and druggable targets in papillary thyroid carcinomas
title_full Proteogenomics analysis unveils a TFG-RET gene fusion and druggable targets in papillary thyroid carcinomas
title_fullStr Proteogenomics analysis unveils a TFG-RET gene fusion and druggable targets in papillary thyroid carcinomas
title_full_unstemmed Proteogenomics analysis unveils a TFG-RET gene fusion and druggable targets in papillary thyroid carcinomas
title_sort proteogenomics analysis unveils a tfg-ret gene fusion and druggable targets in papillary thyroid carcinomas
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/d0a0473fc75243f2b229229426d6900d
work_keys_str_mv AT aswinikrishnan proteogenomicsanalysisunveilsatfgretgenefusionanddruggabletargetsinpapillarythyroidcarcinomas
AT jeanberthelet proteogenomicsanalysisunveilsatfgretgenefusionanddruggabletargetsinpapillarythyroidcarcinomas
AT emilierenaud proteogenomicsanalysisunveilsatfgretgenefusionanddruggabletargetsinpapillarythyroidcarcinomas
AT sebastianrosigkeit proteogenomicsanalysisunveilsatfgretgenefusionanddruggabletargetsinpapillarythyroidcarcinomas
AT utedistler proteogenomicsanalysisunveilsatfgretgenefusionanddruggabletargetsinpapillarythyroidcarcinomas
AT ericstawiski proteogenomicsanalysisunveilsatfgretgenefusionanddruggabletargetsinpapillarythyroidcarcinomas
AT jingwang proteogenomicsanalysisunveilsatfgretgenefusionanddruggabletargetsinpapillarythyroidcarcinomas
AT zoramodrusan proteogenomicsanalysisunveilsatfgretgenefusionanddruggabletargetsinpapillarythyroidcarcinomas
AT marcfiedler proteogenomicsanalysisunveilsatfgretgenefusionanddruggabletargetsinpapillarythyroidcarcinomas
AT mariannbienz proteogenomicsanalysisunveilsatfgretgenefusionanddruggabletargetsinpapillarythyroidcarcinomas
AT stefantenzer proteogenomicsanalysisunveilsatfgretgenefusionanddruggabletargetsinpapillarythyroidcarcinomas
AT arnoschad proteogenomicsanalysisunveilsatfgretgenefusionanddruggabletargetsinpapillarythyroidcarcinomas
AT wilfriedroth proteogenomicsanalysisunveilsatfgretgenefusionanddruggabletargetsinpapillarythyroidcarcinomas
AT berndthiede proteogenomicsanalysisunveilsatfgretgenefusionanddruggabletargetsinpapillarythyroidcarcinomas
AT somasekarseshagiri proteogenomicsanalysisunveilsatfgretgenefusionanddruggabletargetsinpapillarythyroidcarcinomas
AT thomasjmusholt proteogenomicsanalysisunveilsatfgretgenefusionanddruggabletargetsinpapillarythyroidcarcinomas
AT krishnarajrajalingam proteogenomicsanalysisunveilsatfgretgenefusionanddruggabletargetsinpapillarythyroidcarcinomas
_version_ 1718386201286672384